PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Kong D et al. PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation. 2016 J. Exp. Med. pmid:27621415
Yamamoto Y et al. Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats. 2008 J. Gastroenterol. Hepatol. pmid:18565023
Rollins MD et al. Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis. 2006 Sep-Oct J. Gastrointest. Surg. pmid:16966031
Santoro MG et al. PGJ2, a new antiviral prostaglandin: inhibition of Sendai virus replication and alteration of virus protein synthesis. 1987 J. Gen. Virol. pmid:3033130
López-Parra M et al. The selective cyclooxygenase-2 inhibitor celecoxib modulates the formation of vasoconstrictor eicosanoids and activates PPARgamma. Influence of albumin. 2005 J. Hepatol. pmid:15629510
Tran-Thi TA et al. Net prostaglandin release by perfused rat liver after stimulation with phorbol 12-myristate 13-acetate. 1988 J. Hepatol. pmid:3166024
Hoffmann R et al. Regulation of interleukin-6 receptor expression in rat Kupffer cells: modulation by cytokines, dexamethasone and prostaglandin E2. 1994 J. Hepatol. pmid:7814800
Gressner OA et al. Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. 2008 J. Hepatol. pmid:18486259
Li L et al. Molecular mechanisms regulating the antifibrogenic protein heme-oxygenase-1 in human hepatic myofibroblasts. 2004 J. Hepatol. pmid:15336443
Tran-Thi TA et al. Effects of hypoxia on the oxygen-dependent metabolism of prostaglandins and adenosine in liver cells. 1994 J. Hepatol. pmid:8071531
Tran-Thi TA et al. Studies on synthesis and degradation of eicosanoids by rat hepatocytes in primary culture. 1987 J. Hepatol. pmid:2828463
Han XQ et al. Advanced glycation end products promote differentiation of CD4(+) T helper cells toward pro-inflammatory response. 2014 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:24496672
Zhang M et al. Peroxisome proliferator-activated receptor-gamma activated by ligands can inhibit human lung cancer cell growth through induction of apoptosis. 2003 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:12973930
Menè P Prostaglandin D2 : a Cinderella of vascular cell biology? 2002 J. Hypertens. pmid:12131515
Negoro H et al. Endogenous prostaglandin D2 synthesis reduces an increase in plasminogen activator inhibitor-1 following interleukin stimulation in bovine endothelial cells. 2002 J. Hypertens. pmid:12131531
Monneret G et al. 15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils. 2002 J. Immunol. pmid:11907120
Schleimer RP et al. Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids. 1986 J. Immunol. pmid:3082976
Marx N et al. Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. 2000 J. Immunol. pmid:10843708
Diab A et al. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. 2002 J. Immunol. pmid:11859145
Nencioni A et al. Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling. 2003 J. Immunol. pmid:14607914
Ruzicka T and Auböck J Arachidonic acid metabolism in guinea pig Langerhans cells: studies on cyclooxygenase and lipoxygenase pathways. 1987 J. Immunol. pmid:3098849
Fujitani Y et al. Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. 2002 J. Immunol. pmid:11751991
Chen CW et al. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. 2003 J. Immunol. pmid:12847270
Peters SP et al. Arachidonic acid metabolism in purified human lung mast cells. 1984 J. Immunol. pmid:6199420
Harris SG et al. 15-deoxy-Delta 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway. 2002 J. Immunol. pmid:11801678
Diaz BL et al. Regulation of prostaglandin endoperoxide synthase-2 and IL-6 expression in mouse bone marrow-derived mast cells by exogenous but not endogenous prostanoids. 2002 J. Immunol. pmid:11801681
Vaidya S et al. 15-Deoxy-Delta12,1412,14-prostaglandin J2 inhibits the beta2 integrin-dependent oxidative burst: involvement of a mechanism distinct from peroxisome proliferator-activated receptor gamma ligation. 1999 J. Immunol. pmid:10570310
Patella V et al. Eosinophil granule proteins activate human heart mast cells. 1996 J. Immunol. pmid:8757629
Murakami M et al. Cyclooxygenase-2-dependent delayed prostaglandin D2 generation is initiated by nerve growth factor in rat peritoneal mast cells: its augmentation by extracellular type II secretory phospholipase A2. 1997 J. Immunol. pmid:9200484
Maier NK et al. The cyclopentenone prostaglandin 15d-PGJ2 inhibits the NLRP1 and NLRP3 inflammasomes. 2015 J. Immunol. pmid:25681332
Luna-Gomes T et al. Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation. 2011 J. Immunol. pmid:22102725
Serghides L and Kain KC Peroxisome proliferator-activated receptor gamma-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-alpha secretion by monocytes/macrophages. 2001 J. Immunol. pmid:11359831
Tsubosaka Y et al. A deficiency in the prostaglandin D2 receptor CRTH2 exacerbates adjuvant-induced joint inflammation. 2014 J. Immunol. pmid:25362177
Lee KH et al. Stimulatory function of gp49A, a murine Ig-like receptor, in rat basophilic leukemia cells. 2000 J. Immunol. pmid:11046024
Hellmann J et al. Increased saturated fatty acids in obesity alter resolution of inflammation in part by stimulating prostaglandin production. 2013 J. Immunol. pmid:23785121
Zhang X et al. Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2. 2001 J. Immunol. pmid:11390455
Wells E et al. Characterization of primate bronchoalveolar mast cells. I. IgE-dependent release of histamine, leukotrienes, and prostaglandins. 1986 J. Immunol. pmid:2431048
Heavey DJ et al. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells. 1988 J. Immunol. pmid:2450136
Wells E et al. Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells. 1986 J. Immunol. pmid:2431049
Parsons WG and Roberts LJ Transformation of prostaglandin D2 to isomeric prostaglandin F2 compounds by human eosinophils. A potential mast cell-eosinophil interaction. 1988 J. Immunol. pmid:3139758
Nencioni A et al. Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gamma. 2002 J. Immunol. pmid:12133943
Rossi AG et al. Regulation of macrophage phagocytosis of apoptotic cells by cAMP. 1998 J. Immunol. pmid:9531319
Mandal AK et al. Yin-yang: balancing act of prostaglandins with opposing functions to regulate inflammation. 2005 J. Immunol. pmid:16272277
Xue L et al. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. 2005 J. Immunol. pmid:16272307
Columbo M et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. 1992 J. Immunol. pmid:1378071
Sarashina H et al. Opposing immunomodulatory roles of prostaglandin D2 during the progression of skin inflammation. 2014 J. Immunol. pmid:24298012
Kobayashi Y et al. Physiological levels of 15-deoxy-Delta12,14-prostaglandin J2 prime eotaxin-induced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-gamma ligation. 2005 J. Immunol. pmid:16237065
Levi-Schaffer F et al. Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro. 1985 J. Immunol. pmid:2413121
Robin JL et al. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. 1985 J. Immunol. pmid:3161947
Lewis RA et al. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. 1982 J. Immunol. pmid:6809826
Ogasawara T et al. Mouse bone marrow-derived mast cells undergo exocytosis, prostanoid generation, and cytokine expression in response to G protein-activating polybasic compounds after coculture with fibroblasts in the presence of c-kit ligand. 1997 J. Immunol. pmid:8977215
Sturm EM et al. Opposing roles of prostaglandin D2 receptors in ulcerative colitis. 2014 J. Immunol. pmid:24929001
Steinke JW et al. Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease. 2014 J. Immunol. pmid:24890720
Tanaka K et al. Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets. 2000 J. Immunol. pmid:10679060
Chevalier E et al. Cutting edge: chemoattractant receptor-homologous molecule expressed on Th2 cells plays a restricting role on IL-5 production and eosinophil recruitment. 2005 J. Immunol. pmid:16081770
Lawrence ID et al. Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity. 1987 J. Immunol. pmid:2444649
Ward C et al. Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism. 2002 J. Immunol. pmid:12055237
Fox CC et al. Isolation and characterization of human intestinal mucosal mast cells. 1985 J. Immunol. pmid:2582045
Zhao W et al. TGF-beta1 attenuates mediator release and de novo Kit expression by human skin mast cells through a Smad-dependent pathway. 2008 J. Immunol. pmid:18981148
Fionda C et al. 15-deoxy-Delta12,14-prostaglandin J2 negatively regulates rankl gene expression in activated T lymphocytes: role of NF-kappaB and early growth response transcription factors. 2007 J. Immunol. pmid:17371958
Schick B et al. Activation of rat serosal mast cells by chymase, an endogenous secretory granule protease. 1984 J. Immunol. pmid:6425408
Levi-Schaffer F et al. Co-culture of human lung-derived mast cells with mouse 3T3 fibroblasts: morphology and IgE-mediated release of histamine, prostaglandin D2, and leukotrienes. 1987 J. Immunol. pmid:2439587
Tada K et al. Induction of cyclooxygenase-2 by secretory phospholipases A2 in nerve growth factor-stimulated rat serosal mast cells is facilitated by interaction with fibroblasts and mediated by a mechanism independent of their enzymatic functions. 1998 J. Immunol. pmid:9794438
Urade Y et al. The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. 1989 J. Immunol. pmid:2509561
Xue L et al. Leukotriene E4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D2. 2012 J. Immunol. pmid:22174450
Yoon HJ et al. Regulation of TLR2 expression by prostaglandins in brain glia. 2008 J. Immunol. pmid:18523308
Bissonnette SL et al. An endogenous prostaglandin enhances environmental phthalate-induced apoptosis in bone marrow B cells: activation of distinct but overlapping pathways. 2008 J. Immunol. pmid:18641309
Equils O et al. Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4. 2001 J. Immunol. pmid:11160291
Patella V et al. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. 1995 J. Immunol. pmid:7533185
Leal-Berumen I et al. Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells. 1995 J. Immunol. pmid:7536779
Cheron A et al. 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process. 2004 J. Immunol. pmid:15187150
Zingarelli B et al. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. 2003 J. Immunol. pmid:14662889
Kuehn HS et al. The phosphoinositide 3-kinase-dependent activation of Btk is required for optimal eicosanoid production and generation of reactive oxygen species in antigen-stimulated mast cells. 2008 J. Immunol. pmid:19017959
Rocklin RE et al. Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2). 1985 J. Immunol. pmid:3160784
White MV et al. Hydrocortisone inhibits rat basophilic leukemia cell mediator release induced by neutrophil-derived histamine releasing activity as well as by anti-IgE. 1991 J. Immunol. pmid:1712816
Lee JH et al. The 15-deoxy-delta 12,14-prostaglandin J2 suppresses monocyte chemoattractant protein-1 expression in IFN-gamma-stimulated astrocytes through induction of MAPK phosphatase-1. 2008 J. Immunol. pmid:19050284
Shiraishi Y et al. Cyclooxygenase-2/prostaglandin D2/CRTH2 pathway mediates double-stranded RNA-induced enhancement of allergic airway inflammation. 2008 J. Immunol. pmid:18097056
Napimoga MH et al. Peroxisome proliferator-activated receptor-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J2, reduces neutrophil migration via a nitric oxide pathway. 2008 J. Immunol. pmid:18097063
Mizutani N et al. Dose-dependent differential regulation of cytokine secretion from macrophages by fractalkine. 2007 J. Immunol. pmid:18025192
Hu ZQ et al. An essential role of prostaglandin E on mouse mast cell induction. 1995 J. Immunol. pmid:7636261
Murakami M et al. IgE-dependent activation of cytokine-primed mouse cultured mast cells induces a delayed phase of prostaglandin D2 generation via prostaglandin endoperoxide synthase-2. 1995 J. Immunol. pmid:7594606
Hammad H et al. Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. 2003 J. Immunol. pmid:14530310
Xue L et al. Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway. 2009 J. Immunol. pmid:19494281
Torres D et al. Prostaglandin D2 inhibits the production of IFN-gamma by invariant NK T cells: consequences in the control of B16 melanoma. 2008 J. Immunol. pmid:18178816
Gosset P et al. Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. 2003 J. Immunol. pmid:12734337
Schulman ES et al. Heterogeneity of human mast cells. 1983 J. Immunol. pmid:6194221
Satoh T et al. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. 2006 J. Immunol. pmid:16888024
Schlezinger JJ et al. Environmental and endogenous peroxisome proliferator-activated receptor gamma agonists induce bone marrow B cell growth arrest and apoptosis: interactions between mono(2-ethylhexyl)phthalate, 9-cis-retinoic acid, and 15-deoxy-Delta12,14-prostaglandin J2. 2004 J. Immunol. pmid:15322177
Si Q et al. 15-deoxy-Delta12,14-prostaglandin J2 inhibits IFN-inducible protein 10/CXC chemokine ligand 10 expression in human microglia: mechanisms and implications. 2004 J. Immunol. pmid:15322215
Massey WA et al. Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacology. 1991 J. Immunol. pmid:1715365
Okayama Y et al. A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI. 2001 J. Immunol. pmid:11254731
Patel HJ et al. Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. 2003 J. Immunol. pmid:12594295
Chen Y et al. Prostaglandin D2 suppresses human NK cell function via signaling through D prostanoid receptor. 2007 J. Immunol. pmid:17709490
Mesquita-Santos FP et al. Cutting edge: prostaglandin D2 enhances leukotriene C4 synthesis by eosinophils during allergic inflammation: synergistic in vivo role of endogenous eotaxin. 2006 J. Immunol. pmid:16424158
Ahmed SR et al. Prostaglandin D2 regulates CD4+ memory T cell trafficking across blood vascular endothelium and primes these cells for clearance across lymphatic endothelium. 2011 J. Immunol. pmid:21715691
Ray DM et al. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms. 2006 J. Immunol. pmid:17015690
Napimoga MH et al. Exogenous administration of 15d-PGJ2-loaded nanocapsules inhibits bone resorption in a mouse periodontitis model. 2012 J. Immunol. pmid:22706081
Nomiya R et al. CRTH2 plays an essential role in the pathophysiology of Cry j 1-induced pollinosis in mice. 2008 J. Immunol. pmid:18390753
Pang L et al. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors. 2003 J. Immunol. pmid:12517972
Schulman ES et al. Histochemical heterogeneity of dispersed human lung mast cells. 1990 J. Immunol. pmid:1692857